
The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.
Jack Bowers is a senior principal scientist at Biologics Process R&D, Merck and Co. (MSD outside of the United States and Canada).

The authors give an overview of scaling approaches and present good scaling practices for the biopharma industry.

January 1st 2024